TELIGENT FDA Approval NDA 050643

NDA 050643

TELIGENT

FDA Drug Application

Application #050643

Documents

Letter2004-05-26
Label2003-05-02
Letter2007-07-31
Letter2014-09-29
Label2004-05-27
Label2007-07-31
Label2014-09-30
Letter2021-05-18
Label2021-05-18

Application Sponsors

NDA 050643TELIGENT

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTIONEQ 15MG BASE/ML0ZINACEF IN PLASTIC CONTAINERCEFUROXIME SODIUM
002INJECTABLE;INJECTIONEQ 30MG BASE/ML1ZINACEF IN PLASTIC CONTAINERCEFUROXIME SODIUM

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1989-04-28STANDARD
LABELING; LabelingSUPPL2AP1995-10-23
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1992-03-30STANDARD
LABELING; LabelingSUPPL4AP1995-02-06STANDARD
LABELING; LabelingSUPPL5AP1994-10-27STANDARD
LABELING; LabelingSUPPL6AP1995-09-29STANDARD
LABELING; LabelingSUPPL7AP1996-12-23STANDARD
LABELING; LabelingSUPPL8AP1996-09-11STANDARD
LABELING; LabelingSUPPL9AP1996-12-23STANDARD
LABELING; LabelingSUPPL10AP2001-07-12STANDARD
LABELING; LabelingSUPPL11AP2001-10-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2001-04-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP2001-11-09STANDARD
LABELING; LabelingSUPPL15AP2004-05-19STANDARD
LABELING; LabelingSUPPL21AP2007-07-30STANDARD
LABELING; LabelingSUPPL22AP2014-09-25STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2013-04-29STANDARD
LABELING; LabelingSUPPL27AP2021-05-16STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL12Null0
SUPPL13Null0
SUPPL15Null9
SUPPL22Null15
SUPPL25Null0
SUPPL27Null7

CDER Filings

TELIGENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50643
            [companyName] => TELIGENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZINACEF IN PLASTIC CONTAINER","activeIngredients":"CEFUROXIME SODIUM","strength":"EQ 15MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ZINACEF IN PLASTIC CONTAINER","activeIngredients":"CEFUROXIME SODIUM","strength":"EQ 30MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"09\/25\/2014","submission":"SUPPL-22","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/050558s069,050643s022lbl.pdf\"}]","notes":"Please see"},{"actionDate":"07\/30\/2007","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/050558s067,050643s021lbl.pdf\"}]","notes":""},{"actionDate":"05\/19\/2004","submission":"SUPPL-15","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/50558slr057,50643slr015_zinacef_lbl.pdf\"}]","notes":""},{"actionDate":"10\/12\/2001","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/50643s11lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ZINACEF IN PLASTIC CONTAINER","submission":"CEFUROXIME SODIUM","actionType":"EQ 15MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ZINACEF IN PLASTIC CONTAINER","submission":"CEFUROXIME SODIUM","actionType":"EQ 30MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2014-09-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.